Stock Research for ALIM

ALIM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALIM Stock Chart & Research Data

The ALIM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALIM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALIM Due diligence Resources & Stock Charts

The ALIM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALIM Detailed Price Forecast - CNN Money CNN View ALIM Detailed Summary - Google Finance
Yahoo View ALIM Detailed Summary - Yahoo! Finance Zacks View ALIM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALIM Trends & Analysis - Trade-Ideas Barrons View ALIM Major Holders - Barrons
NASDAQ View ALIM Call Transcripts - NASDAQ Seeking View ALIM Breaking News & Analysis - Seeking Alpha
Spotlight View ALIM Annual Report - CompanySpotlight.com OTC Report View ALIM OTC Short Report - OTCShortReport.com
TradeKing View ALIM Fundamentals - TradeKing Charts View ALIM SEC Filings - Bar Chart
WSJ View Historical Prices for ALIM - The WSJ Morningstar View Performance/Total Return for ALIM - Morningstar
MarketWatch View the Analyst Estimates for ALIM - MarketWatch CNBC View the Earnings History for ALIM - CNBC
StockMarketWatch View the ALIM Earnings - StockMarketWatch MacroAxis View ALIM Buy or Sell Recommendations - MacroAxis
Bullish View the ALIM Bullish Patterns - American Bulls Short Pains View ALIM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALIM Stock Mentions - StockTwits PennyStocks View ALIM Stock Mentions - PennyStockTweets
Twitter View ALIM Stock Mentions - Twitter Invest Hub View ALIM Investment Forum News - Investor Hub
Yahoo View ALIM Stock Mentions - Yahoo! Message Board Seeking Alpha View ALIM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALIM - SECform4.com Insider Cow View Insider Transactions for ALIM - Insider Cow
CNBC View ALIM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALIM - OTC Markets
Yahoo View Insider Transactions for ALIM - Yahoo! Finance NASDAQ View Institutional Holdings for ALIM - NASDAQ


Stock Charts

FinViz View ALIM Stock Insight & Charts - FinViz.com StockCharts View ALIM Investment Charts - StockCharts.com
BarChart View ALIM Stock Overview & Charts - BarChart Trading View View ALIM User Generated Charts - Trading View




Latest Financial News for ALIM


Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update
Posted on Tuesday April 30, 2024

Conference Call to be held the same day at 9:00am Eastern TimeATLANTA, April 30, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces today that it will report first quarter financial results on May 14, 2024, prior to the market open. Management will host a conference call at 9:00 AM ET on the sam


Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted on Wednesday March 20, 2024

ATLANTA, March 20, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera” or the “Company”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better vision longer, today announced that, pursuant to Nasdaq Listing Rule 5635(c)(4) and in connection with the appointments of (i) Mr. Todd Wood as President of U.S. Operations of the Company, (ii) Mr. Elliot Maltz as Chief Financial


Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
Posted on Tuesday March 19, 2024

Protocol AL is studying ILUVIEN or faricimab (6.0 mg) injections versus observation for the prevention of visual acuity loss due to radiation retinopathy ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announces that the first patient has been randomized in the DRCR Retina Network’


Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript
Posted on Friday March 08, 2024

Alimera Sciences, Inc. (NASDAQ:ALIM) Q4 2023 Earnings Call Transcript March 7, 2024 Alimera Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Good morning and welcome to the Alimera Sciences Fourth […]


Stock Market & Investing Books

Enter a stock symbol to view the stock details.